envelop
virus
enter
target
cell
two
step
process
initi
event
attach
virion
cell
surfac
subsequ
viral
envelop
fuse
cellular
membran
enabl
viral
genom
get
access
cytoplasm
fusion
reaction
may
occur
plasma
membran
upon
endocytot
uptak
virion
endosom
membran
entri
process
requir
interact
one
viral
surfac
protein
cellular
receptor
bind
cellular
receptor
mediat
attach
step
set
stage
subsequ
fusion
process
sever
virus
develop
strategi
recogn
one
surfac
structur
target
cell
bind
interact
partner
may
suffici
viru
proceed
fusion
step
nevertheless
support
entri
process
make
like
viru
find
actual
cellular
receptor
tgev
porcin
coronaviru
caus
diarrhea
pig
age
piglet
even
die
infect
unless
protect
matern
antibodi
envelop
viru
positivestrand
rna
genom
enter
cell
use
glycoprotein
attach
cell
surfac
fusion
viral
membran
cellular
membran
fusion
activ
protein
induc
interact
specif
receptor
surfac
target
cell
porcin
aminopeptidas
n
papn
protein
abl
bind
papn
also
sialic
acid
bind
activ
prefer
nglycolylneuramin
acid
interact
sialyl
macromolecul
appear
dispens
infect
cultur
cell
believ
import
enteropathogen
viru
base
find
singl
mutat
protein
may
result
loss
sialic
acid
bind
activ
enteropathogen
wherea
mutant
virus
propag
cultur
cell
titer
parent
viru
find
explain
environment
condit
intestin
make
difficult
microorgan
initi
intestin
infect
compar
infect
cultur
cell
intestin
epithelium
cover
glycocalix
layer
also
even
thicker
layer
mucu
mucin
rich
sialic
acid
interact
partner
tgev
thu
may
help
penetr
mucu
layer
get
access
papn
surfac
intestin
epitheli
cell
tri
obtain
experiment
evid
role
sialic
acid
bind
activ
tgev
infect
cell
unfavor
condit
analysi
use
purdu
strain
tgev
grown
swine
testicular
cell
st
describ
previous
analyz
effect
desialyl
cell
infect
tgev
plaqu
assay
contrast
regular
plaqu
assay
neuraminidas
treatment
prior
infect
includ
see
potenti
reduct
number
plaqu
evalu
optim
experiment
setup
differ
neuraminidas
concentr
includ
first
analysi
muml
data
shown
concentr
muml
result
signific
inhibit
tgev
infect
adsorpt
time
min
cell
cultur
appear
disturb
concentr
decid
use
neuraminidas
concentr
muml
subsequ
experi
higher
concentr
enzym
uml
gave
increas
viru
inhibit
conclud
sialic
acid
remov
satisfactori
level
shown
figur
column
design
tgev
tabl
pretreat
cell
neuraminidas
clostridium
perfringen
type
v
muml
sigma
min
reduc
infect
parent
viru
adsorpt
time
min
viru
min
adsorpt
infect
desialyl
cell
reduc
infect
min
adsorpt
time
two
valu
reduct
result
consist
previou
work
bind
virion
rather
infect
analyz
shown
desialyl
cultur
cell
reduc
bind
tgev
particl
cell
data
indic
sialic
acid
bind
activ
increas
effici
infect
short
adsorpt
time
conclus
support
find
reduct
observ
hemagglutin
defici
mutant
subject
analysi
figur
tabl
mutant
point
mutat
protein
posit
leupro
select
defici
sialic
acid
bind
mutant
delet
amino
acid
posit
point
mutat
amino
acid
analyz
way
adsorpt
time
min
fact
mutant
virus
defici
sialic
acid
bind
activ
pretreat
cell
neuraminidas
even
increas
infect
increas
signific
mutant
pvalu
tabl
previou
public
conclud
bind
protein
papn
even
effici
neuraminidas
treatment
sialic
acid
deplet
papn
facilit
protein
bind
possibl
effect
make
easier
mutant
get
access
cellular
receptor
papn
bind
specif
bind
site
neuraminidas
treatment
cell
cultur
contrast
porcin
intestin
bind
mutant
papn
could
less
effici
presenc
sialic
acid
report
enteropathogen
markedli
reduc
therefor
less
effici
bind
cellular
receptor
papn
vivo
defici
sialic
acid
bind
could
one
explan
reduc
enteropathogen
includ
anoth
tgev
strain
studi
analyz
miller
strain
strain
mainli
passag
vivo
enter
respiratori
tropism
like
purdu
strain
virul
swine
shown
figur
tabl
miller
strain
show
reduct
infect
neuraminidas
pretreat
cell
reduct
rang
irrespect
virion
adsorpt
time
reduct
min
reduct
min
tabl
reduct
min
adsorpt
time
recent
shown
infecti
bronchiti
viru
ibv
avian
coronaviru
use
sialic
acid
receptor
determin
infect
cultur
cell
tracheal
organ
cultur
interest
know
whether
viru
also
show
differ
depend
sialic
acid
bind
activ
short
long
adsorpt
time
shown
figur
tabl
analyz
way
tgev
beaudett
strain
ibv
show
reduct
infect
pretreat
cell
neuraminidas
similar
result
obtain
miller
strain
reduct
irrespect
long
short
adsorpt
time
min
adsorpt
infect
ibv
reduc
min
adsorpt
time
reduc
taken
togeth
result
indic
miller
strain
tgev
rather
resembl
ibv
purdu
strain
tgev
far
sialic
acid
depend
infect
concern
infecti
titer
three
differ
time
point
min
without
neuraminidas
treatment
calcul
figur
show
mean
valu
differ
experi
tgev
differ
experi
tgev
miller
highest
titer
pfuml
min
pfuml
min
pfuml
min
obtain
tgev
increas
time
neuraminidas
treatment
titer
decreas
significantli
first
two
time
point
pfuml
min
pfuml
min
pfuml
min
infecti
titer
hemagglutin
defici
mutant
pfuml
min
adsorpt
time
pfuml
min
pfuml
min
neuraminidas
treatment
titer
increas
pfuml
min
pfuml
min
pfuml
min
tgev
miller
strain
infecti
titer
cell
cultur
lower
tgev
purdu
strain
pfuml
min
pfuml
min
pfuml
min
neuraminidas
treatment
titer
tgev
miller
decreas
pfuml
min
pfuml
min
pfuml
min
differ
titer
earli
min
late
min
infect
tgev
tgev
miller
statist
signific
p
higher
titer
tgev
show
viru
strain
cell
cultur
adapt
miller
strain
earli
infect
min
adsorpt
time
valu
tgev
time
point
p
howev
late
infect
min
valu
tgev
p
higher
differ
tgev
earli
infect
could
explain
addit
use
sialic
acid
adsorpt
tgev
short
adsorpt
time
import
sialic
acid
bind
infect
pronounc
longer
adsorpt
time
bind
cellular
receptor
papn
compens
phenomenon
find
sialic
acid
bind
activ
tgev
protein
inhibit
porcin
intestin
mucin
rich
sialic
acid
perform
plaqu
assay
incub
tgev
differ
mucin
concentr
describ
materi
method
section
figur
show
tgev
infect
inhibit
mucin
concentr
depend
manner
preincub
parent
viru
mg
mucinml
reduc
infect
viru
adsorpt
time
min
previou
studi
shown
bind
porcin
intestin
mucin
inhibit
hemagglutin
tgev
thu
sialic
acid
bind
tgev
protein
appear
inhibit
interact
test
mucin
result
pictur
aris
coronavirus
develop
differ
strategi
make
use
sialic
acid
bind
activ
coronavirus
differenti
three
distinct
group
tgev
repres
first
group
recogn
papn
effici
contribut
sialic
acid
bind
activ
infect
cultur
cell
remain
unrecogn
far
bind
papn
independ
sialic
acid
even
appear
effici
less
sialic
acid
present
papn
interact
papn
appear
slower
process
compar
sialic
acid
bind
thu
effect
produc
sialic
acid
bind
recogn
short
adsorpt
time
papn
bind
still
incomplet
reduc
adsorpt
time
could
show
bind
sialoglycoconjug
cell
surfac
increas
effici
tgev
infect
cultur
cell
strain
sialic
acid
bind
activ
may
requir
surviv
unfavor
condit
encount
intestin
tract
interestingli
miller
strain
tgev
show
signific
differ
infect
effici
long
short
adsorpt
time
neuraminidasetr
cell
observ
purdu
strain
appear
gradual
differ
import
sialic
acid
bind
activ
differ
tgev
strain
miller
strain
tgev
resembl
ibv
depend
sialic
acid
bind
activ
two
virus
repres
second
group
coronavirus
concern
sialic
acid
bind
activ
pretreat
variou
cell
type
neuraminidas
shown
reduc
sensit
infect
differ
strain
ibv
protein
receptor
far
identifi
avian
coronaviru
presenc
receptor
exclud
third
group
coronavirus
sialic
acid
bind
activ
repres
virus
like
bovin
coronaviru
bcov
human
coronaviru
virus
resembl
influenza
c
viru
prefer
acid
also
contain
acetylesteras
function
receptordestroy
enzym
presenc
enzym
prefer
less
common
type
sialic
acid
consist
higher
affin
respect
type
sialic
acid
hand
ibv
lack
receptordestroy
enzym
requir
larger
amount
sialic
acid
cell
surfac
sendai
viru
influenza
virus
thu
lower
affin
sialic
acid
latter
virus
contain
neuraminidas
receptordestroy
enzym
three
group
coronavirus
sialic
acid
bind
activ
may
repres
differ
stage
evolutionari
process
use
sialic
acid
infect
acquisit
sialic
acid
bind
activ
increas
effici
infect
unfavor
condit
tgevpurdu
ii
modul
bind
activ
exploit
sialic
acid
gener
receptor
determin
attach
target
cell
tgevmil
ibv
iii
increas
attach
effici
acquir
enzym
inactiv
sialoglycoconjug
prevent
spread
infect
bcov
coronavirus
character
one
highest
recombin
frequenc
among
rna
virus
way
acquir
new
properti
recombin
event
ancestr
coronaviru
might
singl
receptor
bind
activ
eg
protein
receptor
therefor
singl
organ
tropism
eg
respiratori
tract
recombin
event
viru
could
acquir
sialic
acid
bind
activ
thu
viru
broaden
tissu
tropism
eg
addit
intestin
tract
increas
chanc
surviv
case
tgev
gradual
differ
viru
sialic
acid
bind
activ
may
accessori
function
render
viru
effici
recombin
event
receptordestroy
enzym
could
acquir
higher
bind
affin
sialic
acid
could
evolv
viru
like
bcov
resembl
influenza
virus
gene
receptordestroy
enzym
could
incorpor
coronaviru
genom
coinfect
cell
coronavirus
influenza
virus
st
swine
testicular
vero
cell
grown
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
st
vero
cell
purdu
strain
tgev
use
throughout
studi
stock
viru
propag
st
cell
incub
h
supernat
harvest
clarifi
centrifug
store
addit
fetal
calf
serum
hemagglutin
defici
mutant
point
mutat
protein
posit
leupro
select
defici
sialic
acid
bind
mutant
delet
amino
acid
posit
point
mutat
amino
acid
cysarg
origin
deriv
tgev
strain
miller
strain
tgev
harvest
incub
h
st
cell
propag
beaudett
strain
ibv
vero
cell
describ
recent
prior
infect
cell
either
treat
neuraminidas
clostridium
perfringen
type
v
sigmaaldrich
st
loui
missouri
usa
dilut
pb
mocktreat
h
comparison
test
virus
concentr
muml
use
compar
effect
differ
neuraminidas
concentr
infect
tgev
neuraminidas
use
concentr
rang
muml
uml
effect
desialyl
cell
tgev
infect
analyz
plaqu
assay
st
cell
either
treat
neuraminidas
see
mocktreat
h
wash
cell
infect
tgev
tgev
mutant
tgev
miller
reduct
plaqu
neuraminidas
treatment
calcul
mean
valu
tgev
miller
independ
experi
plaqu
reduct
assay
ibv
beaudett
perform
vero
cell
describ
previous
plaqu
reduct
calcul
mean
valu
independ
experi
viru
dilut
medium
incub
differ
concentr
porcin
intestin
mucin
mgml
min
room
temperatur
st
cell
wash
incub
min
sampl
subsequ
plaqu
assay
perform
describ
plaqu
reduct
mucin
treatment
calcul
mean
valu
independ
experi
quadrupl
pvalu
calcul
microsoft
offic
excel
use
student
ttest
singl
side
type
one
p
consid
indic
statist
signific
differ
author
declar
compet
interest
csw
carri
design
studi
analyz
data
perform
statist
analysi
draft
manuscript
sb
particip
analysi
data
perform
plaqu
assay
cw
particip
ibv
analysi
gh
conceiv
studi
particip
design
coordin
help
draft
manuscript
le
hl
particip
design
studi
author
read
approv
final
manuscript
